Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)

NCT00763321 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

287

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Low Back Pain

Interventions

DRUG: ABT-712
DRUG: Placebo

Sponsor

AbbVie (prior sponsor, Abbott)